MLMCX | RNPHX | MLMCX / RNPHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 9 years | - |
Gain YTD | 4.511 | 4.639 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 40.9M | 148B | 0% |
Annual Yield % from dividends | 0.00 | 1.00 | - |
Returns for 1 year | 16.76 | 10.58 | 158% |
Returns for 3 years | 31.84 | 14.84 | 215% |
Returns for 5 years | 53.65 | 34.72 | 155% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
KDHCX | 56.24 | -0.08 | -0.14% |
DWS CROCI Equity Dividend C | |||
GQGRX | 16.52 | -0.13 | -0.78% |
GQG Partners Emerging Markets Equity R6 | |||
TQMVX | 17.90 | -0.22 | -1.21% |
T. Rowe Price Integrated US LCV Eq | |||
NBGTX | 29.41 | -0.58 | -1.93% |
Neuberger Berman Large Cap Growth Tr | |||
FSCAX | 31.55 | -0.63 | -1.96% |
Nuveen Small Cap Value A |